192 related articles for article (PubMed ID: 35077026)
1. Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries.
Saito E; Yano T; Hori M; Yoneoka D; Matsuda T; Chen Y; Katanoda K
Cancer Med; 2022 Mar; 11(5):1347-1356. PubMed ID: 35077026
[TBL] [Abstract][Full Text] [Related]
2. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma.
Matsuno K; Ishihara R; Ohmori M; Iwagami H; Shichijyo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T; Morishima T; Miyashiro I
J Gastroenterol; 2019 Sep; 54(9):784-791. PubMed ID: 30927083
[TBL] [Abstract][Full Text] [Related]
3. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.
Abrams JA; Sharaiha RZ; Gonsalves L; Lightdale CJ; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):183-6. PubMed ID: 21127287
[TBL] [Abstract][Full Text] [Related]
4. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
Arnold M; Laversanne M; Brown LM; Devesa SS; Bray F
Am J Gastroenterol; 2017 Aug; 112(8):1247-1255. PubMed ID: 28585555
[TBL] [Abstract][Full Text] [Related]
5. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan.
Koizumi S; Motoyama S; Iijima K
J Gastroenterol; 2018 Jul; 53(7):827-833. PubMed ID: 29134330
[TBL] [Abstract][Full Text] [Related]
6. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
[TBL] [Abstract][Full Text] [Related]
7. Changing trends in cancer incidence of upper aerodigestive tract and stomach in Japanese alcohol-dependent men (1993-2018).
Yokoyama A; Omori T; Yokoyama T
Cancer Med; 2020 Jan; 9(2):837-846. PubMed ID: 31957322
[TBL] [Abstract][Full Text] [Related]
8. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database.
Cooper SC; Trudgill NJ
Cancer Causes Control; 2012 Jun; 23(6):819-25. PubMed ID: 24251326
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry.
Cummings LC; Cooper GS
Cancer Detect Prev; 2008; 32(1):87-92. PubMed ID: 18406068
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
[TBL] [Abstract][Full Text] [Related]
11. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.
Lin Y; Wang HL; Fang K; Zheng Y; Wu J
Esophagus; 2022 Oct; 19(4):560-568. PubMed ID: 35689719
[TBL] [Abstract][Full Text] [Related]
12. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014.
Islami F; DeSantis CE; Jemal A
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):429-439. PubMed ID: 29902641
[TBL] [Abstract][Full Text] [Related]
13. Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects.
Derakhshan MH; Arnold M; Brewster DH; Going JJ; Mitchell DR; Forman D; McColl KE
Am J Gastroenterol; 2016 Feb; 111(2):228-39. PubMed ID: 26753891
[TBL] [Abstract][Full Text] [Related]
14. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
15. Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001.
Shibata A; Matsuda T; Ajiki W; Sobue T
Jpn J Clin Oncol; 2008 Jul; 38(7):464-8. PubMed ID: 18664481
[TBL] [Abstract][Full Text] [Related]
16. Marital status, education, and income in relation to the risk of esophageal and gastric cancer by histological type and site.
Lagergren J; Andersson G; Talbäck M; Drefahl S; Bihagen E; Härkönen J; Feychting M; Ljung R
Cancer; 2016 Jan; 122(2):207-12. PubMed ID: 26447737
[TBL] [Abstract][Full Text] [Related]
17. Regional variations in esophageal cancer rates by census region in the United States, 1999-2008.
Drahos J; Wu M; Anderson WF; Trivers KF; King J; Rosenberg PS; Eheman C; Cook MB
PLoS One; 2013; 8(7):e67913. PubMed ID: 23861830
[TBL] [Abstract][Full Text] [Related]
18. Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study.
Al-Kaabi A; Baranov NS; van der Post RS; Schoon EJ; Rosman C; van Laarhoven HWM; Verheij M; Verhoeven RHA; Siersema PD
Acta Oncol; 2022 May; 61(5):545-552. PubMed ID: 35112634
[TBL] [Abstract][Full Text] [Related]
19. Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy.
Zagari RM; Marasco G; Tassi V; Ferretti S; Lugaresi M; Fortunato F; Bazzoli F; Mattioli S
Am J Gastroenterol; 2021 Feb; 116(2):289-295. PubMed ID: 33009050
[TBL] [Abstract][Full Text] [Related]
20. Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.
Liu S; Dai JY; Yao L; Li X; Reid B; Self S; Ma J; Chang Y; Feng S; Tapsoba Jde D; Sun X; Sun X
PLoS One; 2014; 9(10):e110348. PubMed ID: 25333822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
